• Resources
  • Blog
  • Journalists
  • Log In
  • Sign Up
  • Data Privacy
  • Send a Release
Cision PR Newswire: news distribution, targeting and monitoring home
  • News
  • Products
    • Overview
    • Distribution by PR Newswire
    • Cision Communications Cloud®
    • Cision IR
    • Sponsored Placement
    • All Products
  • Contact
    • General Inquiries
    • Request a Demo
    • Editorial Bureaus
    • Partnerships
    • Media Inquiries
    • Worldwide Offices

 

When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • Sponsored Placement
  • All Products
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • Overview
  • Distribution by PR Newswire
  • Cision Communications Cloud®
  • Cision IR
  • All Products
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Sign Up
  • Log In
  • Resources
  • Blog
  • Journalists
  • RSS
  • GDPR

US Doctors Support Legalized Cannabis

With 4/20 upon us, it's high time for doctors to weigh in on marijuana - both medicinal and otherwise…

SERMO.com

News provided by

SERMO

Apr 20, 2015, 03:33 ET

Share this article

Share this article


NEW YORK, April 20, 2015 /PRNewswire/ -- 68 percent of US physicians support legalized cannabis says a recent poll by SERMO, the top social network exclusively for doctors. SERMO polled 2,278 doctors and found that 68 percent of physicians support some form of legalized cannabis. SERMO physicians index closely to the demographics of American physicians in general, as benchmarked by the AMA. The margin of error when projecting this un-weighted poll to active SERMO members is ±2 percent (see "A note on the data" for details).

Out of the 68 percent of doctors who support cannabis legalization:

Continue Reading
SERMO Marijuana Poll Results from April 20, 2015
SERMO Marijuana Poll Results from April 20, 2015

  • 34 percent support legalization for both medical and recreational purposes
  • 31 percent support legalization for medical purposes only
  • 3 percent support legalization for recreational purposes only

One SERMO oncologist gave his verdict on marijuana: "This drug is far less dangerous to one's health than another drug that is already legal: alcohol."

Why do 68 percent of doctors support legalized cannabis?

The poll sparked a heated debate within SERMO, a virtual doctors' lounge that provides a safe online space for doctors to discuss all aspects of medicine candidly. Doctors who are able to prescribe medical marijuana legally spoke of their experiences:

"I have seen firsthand [marijuana-derived] cannabidiol (CBD) extract given to patients for seizures, muscle spasms, and bladder [issues] seen in many MS patients…in the majority of the cases it works very well, alleviating or greatly reducing the aforementioned symptoms."

Some patients with psychiatric issues may also benefit from medical marijuana, as a Colorado-based psychiatrist reported:

"I have seen a few PTSD patients who have diligently sought out specific cannabis strains and do extremely well on proper medical marijuana edibles."

A general practitioner spoke from personal experience:

"I have cancer and am in the midst of chemotherapy. My oncologist added [a synthetic version of THC (the principal psychoactive agent of cannabis)] and my nausea is mostly gone; I still feel like crap for a week after each chemo treatment, but it's much better than feeling like nauseated crap."

Doctors also felt that legalization would mean a taxed, regulated, and therefore safer product, referring to the current quality and safety of 'street marijuana' as a "crapshoot."

But while many doctors believe that the medical potential of cannabis "largely remains untapped," not everyone was eager to prescribe marijuana, which some considered akin to "dumping 480 different chemicals into a body without having any idea what the interactions are."

32 percent of doctors think cannabis should remain illegal

Some doctors were willing to admit that a lack of clinical knowledge contributes to their reservations regarding legal cannabis. One oncologist confessed:

"I'm scared of pot just because it's always been illegal and I don't know anything about it. I wouldn't go on the record recommending [cannabis] outside of treatment for cancer symptoms."

But with cannabis classed as a Schedule I drug, opportunities for further scientific research are severely curtailed by government regulations. As one pediatrician said:

"At the present state of research, it is undesirable for doctors to "prescribe" [cannabis]. At the same time, the current status of the plant as Schedule I is quite absurd and…impedes unbiased scientific inquiry. No other drug on the planet is treated in this manner."

Medical cannabis can make doctors the 'gatekeepers' to patient's drug of choice

Doctors who support legalization for recreational purposes are concerned that limiting legalization to only medical cannabis would make physicians the "gatekeepers to patients' drug of choice."

Many physicians emphasized that they didn't care what their patients did to relax, be it cannabis or alcohol, as long the use was both responsible and in moderation. One general practitioner took a more practical and political stance in his support for legalized cannabis:

"I don't like weed personally. I have no plans to use it myself, [and I] don't want my kids to use it, but the incredible waste of time, money, and effort that have gone into maintaining the illegality of this substance is monumentally stupid."

Doctors' reservations regarding prescribing medical cannabis

When SERMO asked 594 doctors about their reservations prescribing cannabis in a separate poll in January of this year:

  • 45 percent were concerned medical marijuana would be used recreationally
  • 34 percent were concerned it would pose a risk to their profession
  • 33 percent said they needed to see more clinical studies
  • 31 percent were concerned about consistent, predictable, and accurate dosages
  • 13 percent had no reservations

With ever-increasing demands on their time, doctors have concerns that legalizing marijuana for only medical purposes will become a burden, as one psychiatrist put it:

"There seems to be a role for cannabis in medicine, but I do not want to deal with being Dr. Pot. I am busy enough."

Opinions have evolved: doctors are now more liberal when it comes to cannabis

These recent poll results showed a marked difference in physician sentiment when compared to a 2012 SERMO poll where 61 percent of physicians (N=593) said they would not prescribe marijuana for medicinal purposes if and when it were legalized in their state.

In the word of one SERMO pathologist:

"Cannabis is by no means a cure all, but to dismiss it out of hand as some of you have, is reprehensible and not keeping with responsible science."

A note on the data

SERMO members must go through a three-stage, highly secure, and accurate verification process. While the data have not been weighted to reflect the demographic composition of US physicians, SERMO physicians index closely to the demographics of American physicians in general, as benchmarked by the AMA. Because the sample is based on those who initially self-select for participation rather than being targeted from a probability sample, no estimates of sampling error can be calculated when projecting to the universe of US Physicians. However, the margin of error when projecting the most recent poll (of 2,278 doctors) to active SERMO members is ±2percent.  The margin of error when projecting the previous polls from January 2015 and November 2012 (of 594 and 593 doctors respectively) is ±4percent. It is calculated at the standard 95percent confidence level. Therefore we can be 95percent confident that the sample result reflects the active SERMO member base within the margin of error. This calculator is based on a 50percent result in a poll, which is where the margin of error is at its maximum. All sample surveys and polls may be subject to multiple sources of error, including, but not limited to sampling error, coverage error, and measurement error.

About SERMO

SERMO is the United States' top ranked social network for fully verified, licensed physicians. SERMO is the place for doctors to talk about real world medicine. Founded in 2005, SERMO's mission is to unite physicians and provide them with a safe, private, and trusted platform for free and open discussions. SERMO is a virtual doctors' 'lounge' where doctors candidly share their true feelings about their profession and lives. It's also a place where doctors learn from one another by asking each other questions, advice, and second opinions about medicine. Over the course of a decade, doctors have built an important medical knowledge bank within SERMO by virtue of those questions and answers. With over 305,000 verified US physicians from 93 specialties, representing 40 percent of the American physician community and 38,000 UK physicians representing 16percent of the UK physician community, SERMO harnesses the collective wisdom of doctors, enabling medical crowdsourcing, knowledge sharing and thus the advancement of medicine.

What are SERMO surveys and sentiment polls?

SERMO is the world's largest healthcare professional polling and survey company with 1.6 million healthcare professional members in both a social network and a digital research network, spanning 80 countries. SERMO conducts 700,000 surveys a year.

In addition to formal surveys, SERMO also conducts regular sentiment polls on the social network. We take the pulse of physicians on topics that range from hot medical issues of the day to healthcare politics and doctors' daily challenges. Polls can receive up to 3,000 votes and members are not incentivized to participate in SERMO polls. Our polls are one of the most popular areas of our site and are intended to reflect the unfiltered voice and sentiment of physicians.

In the US network, SERMO physicians index very closely to the demographics of American physicians, meaning SERMO polls often reflect a strong cross-section of US medical opinion. As SERMO expands to the UK and soon globally, polls can be targeted at specific countries to assess opinion on issues of national importance and relevance. Opinion polls within the social network are open and offered free of charge to members of the media.

Learn more at SERMO.com

Media Contacts:
Osnat Benshoshan, SVP, Marketing & Strategy, SERMO 
[email protected]; +1.805.479.8343

Victoria Khamsombath, SHIFT Communications
[email protected]; +1.617.779.1859

Kristin Polman, Shine Communications 
[email protected]

Photo - http://photos.prnewswire.com/prnh/20150420/199731-INFO
Logo - http://photos.prnewswire.com/prnh/20150113/169025LOGO

SOURCE SERMO

Related Links

http://www.sermo.com/

Modal title

Contact Cision

  • Cision Distribution 888-776-0942
    from 8 AM - 9 PM ET

  • Chat with an Expert
  • General Inquiries
  • Request a Demo
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • Cision Communication Cloud®
  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • For Small Business
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • COVID-19 Resources
  • Accessibility Statement
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom

My Services

  • All New Releases
  • Online Member Center
  • ProfNet

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2022 Cision US Inc.